Quest Diagnostics Reports First Quarter 2026 Financial Results

Quest Diagnostics Incorporated reported strong first quarter financial results for 2026, achieving over 9% revenue growth and approximately 13% adjusted diluted earnings per share (EPS) growth. As a result of this robust performance, the company has raised its revenue and EPS guidance for the full year. Key figures include net revenues of $2.895 billion, an increase in operating income, and a positive change in net income attributable to the company. The updated guidance for full year 2026 reflects expectations of continued growth in both revenues and EPS.